Hypnion

Hypnion develops sleep disorder therapeutics using their proprietary platform SCORE-2000™.

History:

Hypnion was acquired by Eli Lilly in 2007 and is now operating as a wholly owned subsidiary.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Northeast

Research Focus:
Disease Therapeutics-Research

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: